The FDA announced on Jan. 22, 2021, that RaySearch America Inc is recalling its RayStation standalone software treatment planning system due to a bug that can produce incorrect radiation therapy results. The agency issued recall number Z-2039-2023 for the voluntary Class II recall.
How to tell if you have it
- Brand: RaySearch America
- Product: RayStation standalone software treatment planning system
- Model numbers: 8B, 8B SP1, 8B SP2, 9A, 9B, 9B SP1, 10A, 10A SP1 and 10B
- Software versions: 8.1, 9.0, 9.1, 9.2, 10.0, 10.1
- UDI-DI codes: 07350002010129, 07350002010204, 07350002010235, 07350002010174, 07350002010266, 07350002010297, 07350002010303, 07350002010365, 07350002010310
- Distribution: AZ, CA, GA & WA
- Units affected: 5 systems
The hazard
A software bug affecting results when using deep learning segmentation followed by geometrical functions can lead to incorrect outcomes. If dose statistics for an incorrectly created region of interest are used to determine plan acceptability, this could potentially lead to an inappropriate plan being approved. The error could result in a more conservative or liberal plan than intended.
Context
GovInfoNow's records show RaySearch America Inc has 1 other recall on record since Feb. 11, 2022. On Feb. 11, 2022, the company issued a RayStation software recall due to an incorrect dose calculation risk involving source to skin distance errors. Other recent recalls of similar products include RayStation Software Recalls (Nov. 28, 2025), RayStation 2024B Software Recall (Nov. 28, 2025) and RayStation/RayPlan Software Recall (Nov. 28, 2025).